NASDAQ:OCGN
Ocugen, Inc.
Ocugen, Inc.'s revenue grew 8.8% in fiscal 2025 to $4.4M while operating margin fell to −1425.7%. Free cash flow was −$57.1M, −1295.0% of revenue.Summary generated from Ocugen, Inc.'s SEC filings. Latest annual report filed Mar 4, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$4.4M
Revenue growth+8.8%
Revenue, 5-yr CAGR+152.5%
Gross marginn/a
Operating margin−1425.7%
Net margin−1537.4%
ROICn/a
Return on equity−776.9%
Debt / equityn/a
Free cash flow−$57.1M
FCF margin−1295.0%
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 | 6 | 4 | 4 |
| Operating income | −58 | −89 | −66 | −55 | −63 |
| Net income | −58 | −87 | −63 | −54 | −68 |
| Free cash flow | −49 | −65 | −73 | −46 | −57 |
Recent filings
- 8-KResults of a shareholder vote
Oct 6, 2026 - 8-KResults of a shareholder vote
Sep 23, 2026 - 4Insider transaction report
Sep 11, 2026 - 8-KRegulation FD disclosure
Sep 8, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - DEF 14AProxy statement
Jul 30, 2026 - 8-KOther events
Jul 13, 2026